Thomas Leung
2020
In 2020, Thomas Leung earned a total compensation of $2M as Former Chief Financial Officer at Avalanche Biotechnologies, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Option Awards | $1,361,364 |
| Salary | $392,000 |
| Other | $1,307 |
| Total | $1,952,671 |
Leung received $1.4M in option awards, accounting for 70% of the total pay in 2020.
Leung also received $198K in non-equity incentive plan, $392K in salary and $1.3K in other compensation.
Rankings
In 2020, Thomas Leung's compensation ranked 5,628th out of 13,090 executives tracked by ExecPay. In other words, Leung earned more than 57.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,628 out of 13,090 | 57th |
Division Manufacturing | 2,324 out of 5,620 | 59th |
Major group Chemicals And Allied Products | 926 out of 2,253 | 59th |
Industry group Drugs | 801 out of 1,953 | 59th |
Industry Biological Products, Except Diagnostic Substances | 195 out of 411 | 53rd |
Source: SEC filing on April 26, 2022.
Leung's colleagues
We found three more compensation records of executives who worked with Thomas Leung at Avalanche Biotechnologies in 2020.